Abstract

Engineering drug delivery systems (DDS) aim to release bioactive cargo to a specific site within the human body safely and efficiently. Hydrogels have been used as delivery matrices in different studies due to their biocompatibility, biodegradability, and versatility in biomedical purposes. Microparticles have also been used as drug delivery systems for similar reasons. The combination of microparticles and hydrogels in a composite system has been the topic of many research works. These composite systems can be injected in loco as DDS. The hydrogel will serve as a barrier to protect the particles and retard the release of any bioactive cargo within the particles. Additionally, these systems allow different release profiles, where different loads can be released sequentially, thus allowing a synergistic treatment. The reported advantages from several studies of these systems can be of great use in biomedicine for the development of more effective DDS. This review will focus on in situ injectable microparticles in hydrogel composite DDS for biomedical purposes, where a compilation of different studies will be analysed and reported herein.

Highlights

  • Gels 2021, 7, 147. https://doi.org/Drug delivery systems (DDS) can be defined as formulations that protect, transport, and release bioactive cargo, such as drugs or other agents, to the human body

  • The combination of microparticles and hydrogels as a composite system for bioactive cargo delivery has been the focus of different studies (Figure 1) [10,11]

  • A sequential injectable silk fibroin microspheres in an alginate hydrogel system was designed by Wu et al [42] for sequential co-delivery of vascular endothelial growth factor (VEGF) and bone morphogenetic protein 9 (BMP9)

Read more

Summary

Introduction

Drug delivery systems (DDS) can be defined as formulations that protect, transport, and release bioactive cargo, such as drugs or other agents (e.g., growth factors), to the human body. The system can directly release drugs/bioactive agents to the surrounding tissues without affecting healthy tissues, preventing unwanted cytotoxicity This localised delivery will be more effective because the drugs will be unloaded directly to the targeted site, acting more efficiently. The combination of microparticles and hydrogels as a composite system for bioactive cargo delivery has been the focus of different studies (Figure 1) [10,11]. The hydrogel will serve as a double barrier for drugs/bioactive agents that are encapsulated within the particles This will guarantee a more prolonged life of the system with a more sustainable release. This review will focus on in situ injectable composite DDS for biomedical applications based on a combination of microparticles and hydrogels. The focus of this review article is the combination of microparticles (at the micrometre scale) in hydrogels

Microparticles in Hydrogel Systems
In Situ Gelation
Gelation before Injection
Microparticle Mixture with the Hydrogel
Particle Release
Surface Charge and Hydrophobicity of the Polymers
Rheological Properties
Swelling
Microparticles in Hydrogel Systems as DDS
In Loco Stability and Drug Release
Sequential Release and Co Delivery
Encapsulation of Hydrophobic Drugs
Cancer Treatment
FU and iron oxide nanoparticles
Cardiovascular Diseases
Spinal Diseases
Cartilage
Objective
Tissue Engineering
Findings
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.